Cystic Fibrosis sufferer denied free drug

(6 Posts)
CFSKate Mon 29-Oct-12 11:38:57

Telegraph

"The trust decided not to obtain Kalydeco on a compassionate basis because the drug company scheme is temporary and the trust would face withdrawing the medication when the scheme stops."

This doesn't make any sense, they are saying she can't have the drug now, because she would only be able to have it temporarily, and then it would be withdrawn when it wasn't free anymore?

But at least if she had it now she could have a bit more life? If the choice is either death now, or a little bit more life on a free drug and then death in a year or so?

Drug company should commit to continuing the supply indefinitely.
Feel for the poor girl and her family, hope some agreement can be made.

Brixtonelf Fri 02-Nov-12 22:14:51

I agree, doesn't make any sense. If she understands that it's only a temporary supply and she's happy to accept that, then what's the problem?

Without knowing more about the scheme it would be difficult to judge whether the drug company would be willing to hand this out indefinitely.
From what I do understand it's targetted at a particular rare subset of sufferers, and putting my drug company finance hat on I'd question whether they would be willing to market it commercially for such a small population.

Taking my hat off again, I feel for her as well. Such a dreadful disease, and a waste of young lives.

edam Sun 04-Nov-12 21:40:25

Horribly inhumane decision by the trust. I wonder whether they are concerned about setting a precedent or something, but whatever, right now they should be focusing on this individual patient and her needs.

CMOTDibbler Sun 04-Nov-12 21:55:56

I agree with the trust - you can't accept a months worth, and then say theres no funding and it will stop. Its unethical.
The drugs company should either commit to supply it free of charge indefinatly, or not at all.

apismalifica Fri 09-Nov-12 21:08:10

Currently the drug costs over £100K a year for each patient, there are only a couple of hundred people who would benefit from it right now as it only works on a specific gating mechanism found in some CF mutations - but the drug company is also trying to go on to develop this drug further so it works for the rest of the CF community, about 8000 people in total. At the current cost he drug bill would be so huge it just wouldn't be possible to manage, it would just be too expensive and run into billions of pounds. There seems to be a stand-off/discussions between the NHS and the drug company over a viable cost. The hope is that the drug company will drop the price to something the NHS can afford and also develop the drug to the next stage where it might tranform the lives of the rest of the cf community.

Join the discussion

Join the discussion

Registering is free, easy, and means you can join in the discussion, get discounts, win prizes and lots more.

Register now